{"nct_id":"NCT05128773","title":"Study of Amcenestrant (SAR439859) Versus Tamoxifen for Patients With Hormone Receptor-positive (HR+) Early Breast Cancer, Who Have Discontinued Adjuvant Aromatase Inhibitor Therapy Due to Treatment-related Toxicity","status":"TERMINATED","status_verified_date":"2025-09","start_date":"2022-02-17","start_date_type":"ACTUAL","primary_completion_date":"2022-10-13","primary_completion_date_type":"ACTUAL","completion_date":"2022-10-13","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["SNY"]}